Summary
44 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 46% a year over the last 3 years.
- It has been profitable 5 years in a row.
What to watch
- The share price is above the Bulios Fair Price.
- Out of every 100 IDR of revenue, only 1.1 IDR is left as net profit.
- Operating profit covers the interest on its debt only 1.4 times.
- It earns only 1.2 IDR a year on every 100 IDR of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 223.5 IDR for 1 IDR of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (IDR)
Diluted EPS (IDR)
Revenue grew by 30% a year over 5 years. Over the last 3 years it grew by 10% a year. Earnings per share grew by 46% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 IDR of revenue goes
- Cost of sales 75 IDR
- Sales and administration 20 IDR
- Taxes and other 4.1 IDR
- Net profit 1.1 IDR
Net profit, industry median (Medical - Care Facilities) 6.7 IDR
Out of every 100 IDR of revenue, 1.1 IDR is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 6.3 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail